Last close ₹1,463.80down ₹67.10 (4.38%)BSE ₹1,464.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,530.90.
52-week range of traded prices to 23 Oct 2026
₹1,299.40Low, 2 Apr 2026₹1,952.50High, 6 Aug 2026
- Next results date: the board meets on 28 Oct 2026 to consider: financial results and fund raising.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,25,522 Cr70th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 Jul 2026
- 21.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 Apr 2026
- 4.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- 21.3%
- NIMNet interest margin. Net interest income ÷ the average assets that earn interest × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 6.79%
- Cost of fundsCost of funds. Interest paid ÷ the average of what the company pays interest on × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 7.43%
- Credit costCredit cost. What was set aside for loans that may not be repaid ÷ average loans given × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 1.77%
- ROAReturn on assets. Profit after tax ÷ average total assets × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. It equals net interest income + other income − operating expenses − provisions + exceptional items − tax + the lines below tax, each on the same base. For the year to Mar 2026.
- 2.34%
- LeverageAssets per rupee of net worth. Average total assets ÷ average net worth: rupees of assets for each rupee of net worth; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 8.26times net worth
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 32,39,30756.0% delivered
Cholamandalam Investment and Finance Company share news and announcements
1,105 announcements, routine notices left out, newest first. Page 20 of 23.
Oct 2011
22 Oct · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on October 25, 2011 to consider and take on record the unaudited financial results for the quarter ended September 30, 2011. The Company has now informed the Exchange that the aforesaid Board Meeting has been rescheduled and will now be held on October 27, 2011.Not held on this date
21 Oct · Business
Compensation & Nomination Committee has approved the allotment of 2,624 equity shares of Rs.10 each to the option grantee who has exercised his options.4 Oct · Board meeting
To consider and take on record the unaudited financial results for the quarter ended September 30, 2011.
Sep 2011
Aug 2011
29 Aug · Business
Compensation & Nomination Committee has approved the allotment of 2,788 equity shares of Rs.10 each to the option grantee who has exercised his options.
Jul 2011
29 Jul · Disclosure
Compensation & Nomination Committee at its meeting held on July 28, 2011 has approved an ESOP grant to some of the employees of the Company on the following terms; - No of options granted: 61,800 - Exercise price: Rs. 175.35/- being the closing price of the equity shares of the Company on July 27, 2011 (the working day prior to the date of committee approving the grant) on NSE being the exchange which recorded the highest trading. - Vesting period: Options would vest only on continued association with the Company and on the employee achieving the performance rating parameters as per the ESOP scheme. Options will vest over a period of 4 years from the date of grant of options. - Exercise period: Options can be exercised anytime within a period of 3 years from the date of each vesting.29 Jul · Board meeting
At the Board meeting re-convened after the AGM held on July 28, 2011, the Board has approved the following: (1) Issue of 1,00,000 short term/ long term, Redeemable, Non Convertible Debentures of a face value of Rs. 10 lakhs each at par in one or more tranches on private placement basis; (2) Issue of 4500 unsecured Redeemable, Non-Convertible Debentures (subordinated debt) of a face value of Rs. 10 lakhs each at par aggregating to Rs. 450 crores in one or more series on private placement basis. (3) Issue of 8000 unsecured Redeemable, Non-Convertible Debentures (perpetual debt) of a face value of Rs. 5 lacs each at par aggregating to Rs. 400 crores in one or more series on private placement basis.29 Jul · Meeting
Following changes in the constitution of the Board of Directors of the Company approved at the Annual General Meeting of the company held on July 28, 2011 :- (1) Mr. V P Mahendra, Director retired as a Director of the Company; (2) Mr. V Srinivasa Rangan is appointed as a Director of the Company.4 Jul · Board meeting
To consider and take on record the unaudited financial results for the quarter ended June 30, 2011.
May 2011
19 May · Business
Compensation & Nomination Committee has approved the allotment of 1,476 equity shares of Rs.10 each to the option grantee who has exercised their options.6 May · Meeting
Annual General Meeting of the Company is scheduled to be held on July 28, 2011 and the Book Closure dates are from July 25, 2011 to July 28, 2011 (both days inclusive) for the purpose of declaration of dividend at the Annual General Meeting.2 May · Dividend
Board of Directors of the Company at its meeting held on April 30, 2011 has approved the payment of dividend @ 15% being Rs.1.50/- per equity share for the year ended March 31, 2011 out of the profits of the Company.
Apr 2011
13 Apr · Business
Compensation & Nomination Committee on April 11, 2011 has approved allotment of 3,652 equity shares of Rs.10 each to the option grantees who have exercised their options.6 Apr · Board meeting
To consider and take on record the audited financial results for the year ended March 31, 2011.
Mar 2011
3 Mar · Board meeting
To consider the business plan of the Company for the financial Year 2011-2012 amongst other items.
Feb 2011
18 Feb · Rating
Company has received letters dated February 09, 2011 from ICRA Limited, re-affirming its existing ratings for the instruments issued by the Company as follows: (1) Medium / Long term debt instruments revised from LAA- Stable to LAA-Positive; (2) Perpetual Debt instruments revised from LA+ Stable to LA+ Positive; (3) Short term debt instruments and working capital facility limits reaffirmed at A1+.
Jan 2011
5 Jan · Board meeting
To consider and take on record the unaudited financial results for the quarter ended December 31, 2010.
Dec 2010
Oct 2010
22 Oct · Rating
Credit Analysis & Research Ltd. (CARE) has assigned 'CARE AA' (Double A) rating for the proposed NCD issue aggregating to Rs.300 Crores. The rating denotes high safety for timely servicing of debt obligations and such instruments carry very low credit risk.7 Oct · Board meeting
To consider and take on record the Unaudited financial results for the quarter ended September 30, 2010.
Sep 2010
Aug 2010
Jul 2010
28 Jul · Board meeting
Board of Director at their meeting held on July 28,2010 approved the following: (1) Issue of equity shares/securities equivalent thereto in one or more tranches up to Rs.150 crores by way of preferential allotment and/or Qualified Institutional Placement in accordance with the SEBI (Issue of Capital and Disclosure Requirements), Regulations, 2009 and (2) Issue of redeemable cumulative preference share up to Rs.100 crores on private placement basis to one or more investors. The approve of the shareholders of the Company for the further issue of shares is proposed to be sought through postal ballot/s and the Board at the meeting has also approved the postal ballot notice for further issue of shares.8 Jul · Board meeting
To consider and take on record the Unaudited financial results for the quarter ended June 30, 2010.1 Jul · Updates
Fitch Ratings on June 29, 2010 has informed the Company that it has vide a press release dated June 23, 2010 revised the outlook on the National Long term Rating for the Company's subordinated debt program from "negative" to "stable".
Jun 2010
16 Jun · Change in Company Name / Symbol
Members of the Exchange are hereby informed that the name of Cholamandalam DBS Finance Limited shall be changed to Cholamandalam Investment and Finance Company Limited and the trading symbol of the Company be changed from CHOLADBS to CHOLAFIN w.e.f. June 22, 2010.
May 2010
11 May · Updates
Cholamandalam Dbs Finance Limited had informed the Exchange regarding the approval of the shareholders of the Company for the issue of 1,08,93,852 equity shares of Rs. 10/- each at a price of Rs. 92/- per equity share aggregating to Rs. 100.23 crores to International Finance Corporation (IFC), member of the World bank on a preferential basis in accordance with the SEBI (Issue of capital & Disclosure Requirements) Regulations, 2009. In this regard, the Company has now informed the Exchange that the Company has on May 11, 2010 signed a subscription agreement with IFC in respect of the above issue.